Spectral Medical Inc.
EDT.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.48M | 1.40M | 1.29M | 1.18M | 1.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.48M | 1.40M | 1.29M | 1.18M | 1.32M |
| Cost of Revenue | 887.60K | 875.20K | 800.80K | 695.20K | 660.90K |
| Gross Profit | 588.50K | 528.80K | 486.70K | 488.80K | 662.20K |
| SG&A Expenses | 9.05M | 8.96M | 8.81M | 8.37M | 7.82M |
| Depreciation & Amortization | 573.20K | 568.80K | 244.30K | 192.20K | 204.10K |
| Other Operating Expenses | 63.60K | 182.70K | 144.70K | 132.90K | 193.90K |
| Total Operating Expenses | 10.57M | 10.59M | 10.00M | 9.39M | 8.88M |
| Operating Income | -9.10M | -9.19M | -8.72M | -8.21M | -7.55M |
| Income Before Tax | -18.42M | -13.84M | -13.81M | -11.54M | -7.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.42 | -13.84 | -13.81 | -11.54 | -7.62 |
| Earnings from Discontinued Operations | -24.30K | -121.20K | -84.70K | -114.30K | -1.06M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.45M | -13.96M | -13.90M | -11.65M | -8.68M |
| EBIT | -9.10M | -9.19M | -8.72M | -8.21M | -7.55M |
| EBITDA | -9.01M | -9.09M | -8.62M | -8.11M | -7.44M |
| EPS Basic | -0.07 | -0.05 | -0.05 | -0.04 | -0.03 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Diluted | -0.07 | -0.05 | -0.05 | -0.04 | -0.03 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 1.12B | 1.12B | 1.12B | 1.11B | 1.11B |
| Average Diluted Shares Outstanding | 1.12B | 1.12B | 1.12B | 1.11B | 1.11B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
